Atara Biotherapeutics, Inc. 8-K

Accession 0001213900-26-068264

Filing information

CIK: 0001604464
Report date: 2026-06-09
Filing date: 2026-06-12
Form: 8-K
Primary document: ea0294561-8k_atara.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.